Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens
NCT02561390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2016-05-04
Summary
The prevalence of Allergic rhinitis(AR) and asthma was increased world wide. In 1998, ISAAC found that prevalence of AR and asthma inThailand was in moderately high group.
Tests for immediated reaction SPT and spIgE, were used for evaluated sensitization of allergen in patient. They guided the investigators for proper management as well as patient education. Clinician will use the result for choose allergen in case that might need immunotherapy.
SPT is safe and more economic for patient. Specific IgE has an advantage in patient who cannot withhold antihistamine prior SPT. In United state had a trial of result between SPT and spIgE for cockroach, cat, house dust mite and mold. It showed the correlation between two tests. In Thailand, the investigators haven't had data about it yet.
Conditions
- Immediate Hypersensitivity
Interventions
- PROCEDURE
-
Skin prick test
skin prick test to American cockroach, dog, cat, dust mite and mold allergen extracts are performed
- OTHER
-
specific IgE measurement
measure specific IgE of American cockroach, dog, cat, dust mite and mold
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Principal Investigators
-
Nualanong Visitsunthorn, Prof · Mahidol University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 10 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Thailand
More Related Trials
-
Immunoblot, Chemiluminescence and ImmunoCap Allergen Specific IgE Evaluation of in Allergic Rhinitis Patients
NCT06137495 ·Status: COMPLETED ·Phase: NA
-
House Dust Mite SLIT in Elderly Patients
NCT01605760 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites
NCT00660452 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885 ·Status: RECRUITING ·Phase: PHASE3
-
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
NCT03649139 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of SLITone in House Dust Mite Allergic Patients
NCT00633919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
NCT05299086 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest
NCT03820154 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
NCT05080322 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
NCT01795846 ·Status: UNKNOWN
-
A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy
NCT00250263 ·Status: COMPLETED ·Phase: PHASE4
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
NCT05570383 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
NCT02443805 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults
NCT06861101 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
NCT04176185 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
NCT01608243 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children
NCT01199133 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis
NCT07052097 ·Status: COMPLETED ·Phase: PHASE2
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
NCT02061709 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy
NCT05448066 ·Status: RECRUITING ·Phase: NA